Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease (Q34068220)

30 July 2017

title

Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease (English)

1 reference

30 July 2017

1

Caroline M Moore

1 reference

30 July 2017

2

Mark Emberton

1 reference

30 July 2017

Stephen G Bown

3

1 reference

30 July 2017

publication date

1 September 2011

1 reference

Lasers in Surgery and Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

43

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

768-775

1 reference

Time trends and local variation in primary treatment of localized prostate cancer

30 July 2017

cites work

1 reference

A short-term cost-effectiveness study comparing robot-assisted laparoscopic and open retropubic radical prostatectomy.

21 January 2018

1 reference

Cost implications of the rapid adoption of newer technologies for treating prostate cancer

21 January 2018

1 reference

Photodynamic therapy for prostatic carcinoma in a dog.

21 January 2018

1 reference

Preliminary results of intraoperative photodynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma.

21 January 2018

1 reference

Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer

21 January 2018

1 reference

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

21 January 2018

1 reference

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX

21 January 2018

1 reference

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin

21 January 2018

1 reference

Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy

21 January 2018

1 reference

Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy

21 January 2018

1 reference

Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation

21 January 2018

1 reference

Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland

21 January 2018

1 reference

The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model

21 January 2018

1 reference

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

21 January 2018

1 reference

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer

21 January 2018

1 reference

In vivo photosensitizer tomography inside the human prostate

21 January 2018

1 reference

Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.

21 January 2018

1 reference

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy

21 January 2018

1 reference

Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy

21 January 2018

1 reference

Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.

21 January 2018

1 reference

Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.

21 January 2018

1 reference

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study

21 January 2018

1 reference

Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.

21 January 2018

1 reference

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen

21 January 2018

1 reference

Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide

21 January 2018

1 reference

Photodynamic therapy for focal ablation of the prostate

21 January 2018

1 reference

Pathologic basis of focal therapy for early-stage prostate cancer

21 January 2018

1 reference

Imaging techniques for prostate cancer: implications for focal therapy

21 January 2018

1 reference

Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer

21 January 2018

1 reference

System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer

21 January 2018

1 reference

Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy

21 January 2018

1 reference

Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption

21 January 2018

1 reference

Choline PET for monitoring early tumor response to photodynamic therapy

21 January 2018

1 reference

Interstitial Doppler optical coherence tomography as a local tumor necrosis predictor in photodynamic therapy of prostatic carcinoma: an in vivo study

21 January 2018

1 reference

Photodynamic therapy for urological malignancies: past to current approaches

21 January 2018

1 reference

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LSM.21104

1 reference

30 July 2017

1 reference